Showing results (331-340 of 566) with videos related to

Sort By:
Pageof 57
The Journal of Rheumatology|May 8, 2003
MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritisGeorge Wells, Maarten Boers, Beverley Shea, et al.
Arthritis Care & Research|May 26, 2017
Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic DataNicolai Leuchten, Annika Hoyer, Ralph Brinks, et al.
Clinical and Experimental Rheumatology|January 9, 2023
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational studyFrank Behrens, Gerd-Rudiger Burmester, Michael W Hofmann, et al.
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Arthritis and Rheumatism|July 19, 2002
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trialMichelle A Petri, Robert G Lahita, Ronald F Van Vollenhoven, et al.
The Journal of Rheumatology|July 5, 2011
Toward development of a fibromyalgia responder index and disease activity score: OMERACT module updatePhilip J Mease, Daniel J Clauw, Robin Christensen, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritisJeremy Sokolove, Vibeke Strand, Jeffrey D Greenberg, et al.
Arthritis Research & Therapy|September 8, 2016
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trialVibeke Strand, Mark Kosinski, Chieh-I Chen, et al.
Arthritis Research & Therapy|September 11, 2015
Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patientsJosef S Smolen, Ronald van Vollenhoven, Arthur Kavanaugh, et al.
RMD Open|March 23, 2023
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extensionLihi Eder, Dafna D Gladman, Philip Mease, et al.
Pageof 57